These blog posts explore GP2’s work in further understanding the genetic architecture of Parkinson’s disease.

  • GP2 and AMP PD: Platform Partners for Progress in Parkinson’s Research

    By GP2 & AMP PD | GP2 Values, Research Collaboration |

    Adding a layer of compute to connect two massive datasets is where we are headed. Mike Nalls, Hampton Leonard, Matt Bookman, and Eline Appelmans outline the partnership between The Global Parkinson’s Genetics Program (GP2) and Accelerating Medicines Partnership: Parkinson's Disease (AMP PD) to be your one-stop shop for PD genetic and genomic data in this new blog post.

  • What is Compliance and Why is it Important?

    By GP2 Operations and Compliance Working Group | Research Operations |

    Members of the GP2 Operations and Compliance working group provide an overview of what compliance is and why it is important in GP2.

  • Understanding GWAS

    By GP2 Complex Disease Data Analysis Working Group | Complex disease genetics |

    Members of the GP2 Complex Disease Data Analysis working group provide an overview of Genome-Wide Association Studies (GWAS), including statistical formulae, workflows, and examples from the most recent Parkinson’s disease GWAS.

  • Parkinson’s Disease Genetics: Cause, Risk, or Protection?

    By Christine Klein | Monogenic disease genetics |

    Christine Klein leads the GP2 Monogenic Hub. In this post Christine shares how her interest in Parkinson’s disease genetics was sparked, which genes have been discovered so far, and the questions which are still to be answered.

  • Decoding the Aliens Within

    By Benjamin Stecher | Patient involvement, Research communication |

    GP2 aims to identify novel disease-causing genes and mutations. Benjamin Stecher outlines his hopes for GP2, as we delve into the unknown and build a foundation of knowledge from which new therapies may come.

  • Open Science Opens Doors

    By Bradford Casey | GP2 Values |

    In GP2, underlying data, analytical processes, and results will be made available to the research community as quickly as possible, with minimal barriers to access and use. The latest blog post by Bradford Casey highlights the value and importance of open science.